Cargando…

Considerations for using distributed research networks to conduct aspects of randomized trials

Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsolo, Keith A., Brown, Jeffrey S., Hernandez, Adrian F., Hammill, Bradley G., Raman, Sudha R., Syat, Beth, Platt, Richard, Curtis, Lesley H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/
https://www.ncbi.nlm.nih.gov/pubmed/31956724
http://dx.doi.org/10.1016/j.conctc.2019.100515
_version_ 1783487913308192768
author Marsolo, Keith A.
Brown, Jeffrey S.
Hernandez, Adrian F.
Hammill, Bradley G.
Raman, Sudha R.
Syat, Beth
Platt, Richard
Curtis, Lesley H.
author_facet Marsolo, Keith A.
Brown, Jeffrey S.
Hernandez, Adrian F.
Hammill, Bradley G.
Raman, Sudha R.
Syat, Beth
Platt, Richard
Curtis, Lesley H.
author_sort Marsolo, Keith A.
collection PubMed
description Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Institutes of Health (NIH) Collaboratory, and the National Patient-Centered Clinical Research Network (PCORnet). DRNs reuse electronic health record (EHR) and claims data for research. The design and use of health data DRNs is complicated by lack of uniformity in data collection, a fragmented healthcare system, and the imperative to protect research participants. We describe the key elements of successful DRNs, as well as methods, challenges, and solutions we have encountered in using DRNs to support different phases of randomized, multi-site, clinical research. This work supports “real-world” efforts to build a learning health system and will enable others to conduct randomized clinical trial research using a DRN.
format Online
Article
Text
id pubmed-6961060
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69610602020-01-17 Considerations for using distributed research networks to conduct aspects of randomized trials Marsolo, Keith A. Brown, Jeffrey S. Hernandez, Adrian F. Hammill, Bradley G. Raman, Sudha R. Syat, Beth Platt, Richard Curtis, Lesley H. Contemp Clin Trials Commun Article Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Institutes of Health (NIH) Collaboratory, and the National Patient-Centered Clinical Research Network (PCORnet). DRNs reuse electronic health record (EHR) and claims data for research. The design and use of health data DRNs is complicated by lack of uniformity in data collection, a fragmented healthcare system, and the imperative to protect research participants. We describe the key elements of successful DRNs, as well as methods, challenges, and solutions we have encountered in using DRNs to support different phases of randomized, multi-site, clinical research. This work supports “real-world” efforts to build a learning health system and will enable others to conduct randomized clinical trial research using a DRN. Elsevier 2020-01-02 /pmc/articles/PMC6961060/ /pubmed/31956724 http://dx.doi.org/10.1016/j.conctc.2019.100515 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Marsolo, Keith A.
Brown, Jeffrey S.
Hernandez, Adrian F.
Hammill, Bradley G.
Raman, Sudha R.
Syat, Beth
Platt, Richard
Curtis, Lesley H.
Considerations for using distributed research networks to conduct aspects of randomized trials
title Considerations for using distributed research networks to conduct aspects of randomized trials
title_full Considerations for using distributed research networks to conduct aspects of randomized trials
title_fullStr Considerations for using distributed research networks to conduct aspects of randomized trials
title_full_unstemmed Considerations for using distributed research networks to conduct aspects of randomized trials
title_short Considerations for using distributed research networks to conduct aspects of randomized trials
title_sort considerations for using distributed research networks to conduct aspects of randomized trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/
https://www.ncbi.nlm.nih.gov/pubmed/31956724
http://dx.doi.org/10.1016/j.conctc.2019.100515
work_keys_str_mv AT marsolokeitha considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT brownjeffreys considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT hernandezadrianf considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT hammillbradleyg considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT ramansudhar considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT syatbeth considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT plattrichard considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials
AT curtislesleyh considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials